Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 5798453, 7 pages
https://doi.org/10.1155/2018/5798453
Research Article

Danhong Injection Alleviates Mechanical Allodynia via Inhibiting ERK1/2 Activation and Elevates BDNF Level in Sciatic Nerve in Diabetic Rat

1Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China
2Department of Neurosurgery, China-Japan Friendship Hospital, Beijing, China
3Department of Rehabilitation, The Affiliated Hospital of Qingdao University, Qingdao, China

Correspondence should be addressed to Yan-Bing Yu; moc.anis@6666gnibnayuy

Received 17 October 2017; Revised 1 December 2017; Accepted 4 December 2017; Published 14 January 2018

Academic Editor: Filippo Maggi

Copyright © 2018 Qi Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. Vincent, B. C. Callaghan, A. L. Smith, and E. L. Feldman, “Diabetic neuropathy: cellular mechanisms as therapeutic targets,” Nature Reviews Neurology, vol. 7, no. 10, pp. 573–583, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Tesfaye and D. Selvarajah, “Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy,” Diabetes/Metabolism Research and Reviews, vol. 28, no. 1, pp. 8–14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Peltier, S. A. Goutman, and B. C. Callaghan, “Painful diabetic neuropathy,” British Medical Journal, vol. 348, Article ID g1799, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Tesfaye, A. J. M. Boulton, and A. H. Dickenson, “Mechanisms and management of diabetic painful distal symmetrical polyneuropathy,” Diabetes Care, vol. 36, no. 9, pp. 2456–2465, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Daulhac, C. Mallet, C. Courteix et al., “Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartate- dependent mechanisms,” Molecular Pharmacology, vol. 70, no. 4, pp. 1246–1254, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Li, J. Zhang, L. Zhang, Q. Cui, and H. Liu, “Angelica injection promotes peripheral nerve structure and function recovery with increased expressions of nerve growth factor and brain derived neurotrophic factor in diabetic rats,” Current Neurovascular Research, vol. 7, no. 3, pp. 213–222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Eslami, R. Gharakhanlou, A. Kazemi, A. B. Dakhili, G. Sorkhkamanzadeh, and A. Sheikhy, “Does endurance training compensate for neurotrophin deficiency following diabetic neuropathy?” Iranian Red Crescent Medical Journal, vol. 18, no. 10, Article ID e37757, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Cotter, A. Love, and N. E. Cameron, “Effects of neurotrophs on nerve function and regeneration in young diabetic rats,” Diabetes, vol. 46, p. 126, 1997. View at Google Scholar
  9. X. Yang, J. Orgah, D. Wang et al., “Danhong injection reduces vascular remodeling and up-regulates the Kallikrein-kinin system in spontaneously hypertensive rats,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  10. Q.-Q. Zhang, X. Dong, X.-G. Liu, W. Gao, P. Li, and H. Yang, “Rapid separation and identification of multiple constituents in Danhong Injection by ultra-high performance liquid chromatography coupled to electrospray ionization quadrupole time-of-flight tandem mass spectrometry,” Chinese Journal of Natural Medicines, vol. 14, no. 2, pp. 147–160, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. H.-T. Liu, Y.-F. Wang, O. Olaleye et al., “Characterization of in vivo antioxidant constituents and dual-standard quality assessment of Danhong injection,” Biomedical Chromatography, vol. 27, no. 5, pp. 655–663, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. C.-X. Li, J.-F. Tang, F. Meng, and X.-L. Li, “Security revaluation study based on nested case-control method of danhong injection,” China Journal of Chinese Materia Medica, vol. 37, no. 18, pp. 2735–2738, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Du, W. Yang, D. Yi, Y. Xie, Y. Zhuang, and Q. Chen, “Analysis of using Danhong injection to treatment coronary heart disease patient's medicines based on real world HIS database,” China Journal of Chinese Materia Medica, vol. 36, no. 20, pp. 2821–2824, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. R. Wu, X. M. Zhang, and B. Zhang, “Danhong injection in the treatment of acute coronary syndrome: a systematic review and meta-analysis,” American Journal of Chinese Medicine, vol. 43, no. 2, pp. 199–214, 2015. View at Publisher · View at Google Scholar
  15. M. Liu, Q. Pan, Y. Chen et al., “Administration of Danhong Injection to diabetic db/db mice inhibits the development of diabetic retinopathy and nephropathy,” Scientific Reports, vol. 5, article 11219, 2015. View at Publisher · View at Google Scholar
  16. W. J. Dixon, “Efficient analysis of experimental observations,” Annual Review of Pharmacology and Toxicology, vol. 20, pp. 441–462, 1980. View at Publisher · View at Google Scholar · View at Scopus
  17. S. R. Chaplan, F. W. Bach, J. W. Pogrel, J. M. Chung, and T. L. Yaksh, “Quantitative assessment of tactile allodynia in the rat paw,” Journal of Neuroscience Methods, vol. 53, no. 1, pp. 55–63, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. H.-P. Mao, X.-Y. Wang, Y.-H. Gao et al., “Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-κb pathway,” Journal of Ethnopharmacology, vol. 186, pp. 20–29, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Wang, F. Song, J. Li et al., “PET demonstrates functional recovery after treatment by danhong injection in a rat model of cerebral ischemic-reperfusion injury,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 430757, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Yang, J. Orgah, J. Zhu et al., “Danhong injection attenuates cardiac injury induced by ischemic and reperfused neuronal cells through regulating arginine vasopressin expression and secretion,” Brain Research, vol. 1642, pp. 516–523, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Ciruela, A. K. Dixon, S. Bramwell, M. I. Gonzalez, R. D. Pinnock, and K. Lee, “Identification of MEK1 as a novel target for the treatment of neuropathic pain,” British Journal of Pharmacology, vol. 138, no. 5, pp. 751–756, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Daulhac, V. Maffre, C. Mallet et al., “Phosphorylation of spinal N-methyl-d-aspartate receptor NR1 subunits by extracellular signal-regulated kinase in dorsal horn neurons and microglia contributes to diabetes-induced painful neuropathy,” European Journal of Pain, vol. 15, no. 2, pp. 169–e12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Purves, A. Middlemas, S. Agthong et al., “A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy,” The FASEB Journal, vol. 15, no. 13, pp. 2508–2514, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. C. G. Jolivalt, M. Fineman, C. F. Deacon, R. D. Carr, and N. A. Calcutt, “GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice,” Diabetes, Obesity and Metabolism, vol. 13, no. 11, pp. 990–1000, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. C. Apfel, S. Schwartz, B. T. Adornato et al., “Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial,” Journal of the American Medical Association, vol. 284, no. 17, pp. 2215–2221, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Wellmer, V. P. Misra, M. K. Sharief, P. G. Kopelman, and P. Anand, “A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy,” Journal of the Peripheral Nervous System, vol. 6, no. 4, pp. 204–210, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Hernandez-Pedro, V. Granados-Soto, G. Ordonez et al., “Vitamin A increases nerve growth factor and retinoic acid receptor beta and improves diabetic neuropathy in rats,” Translational Research, vol. 164, no. 3, pp. 196–201, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Suzuki, H. Sekido, N. Kato, Y. Nakayama, and C. Yabe-Nishimura, “Neurotrophin-3-induced production of nerve growth factor is suppressed in Schwann cells exposed to high glucose: Involvement of the polyol pathway,” Journal of Neurochemistry, vol. 91, no. 6, pp. 1430–1438, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Tosaki, H. Kamiya, Y. Yasuda et al., “Reduced NGF secretion by Schwann cells under the high glucose condition decreases neurite outgrowth of DRG neurons,” Experimental Neurology, vol. 213, no. 2, pp. 381–387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. Y.-K. Zhou, Z. Liang, Y. Guo, H.-T. Zhang, and K.-H. Wang, “High glucose upregulates CYP24A1 expression which attenuates the ability of 1,25(OH)2D3 to increase NGF secretion in a rat Schwann cell line RSC96,” Molecular and Cellular Endocrinology, vol. 404, pp. 75–81, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Zhu, W.-J. Yu, Y. Le et al., “High glucose levels increase the expression of neurotrophic factors associated with p-p42/p44 MAPK in Schwann cells in5 vitro,” Molecular Medicine Reports, vol. 6, no. 1, pp. 179–184, 2012. View at Publisher · View at Google Scholar · View at Scopus